7 firms writing Biotech checks in Boulder, led by True Ventures, Allen & Company, Connecticut Innovations — ranked by verified deal count with the companies.
Biotech in Boulder accounts for 4 tracked companies with verified cap-table data, 4 of which disclose round sizes totalling $964M. The median disclosed raise is $230M, and the largest is Edgewise Therapeutics at $495M, ahead of Enveda Biosciences ($230M) and Ambrosia Biosciences ($141M).
The names that recur most often on these biotech cap tables are Janus Henderson Investors (2 companies), OrbiMed (1 company), Novo Holdings (1 company), RA Capital (1 company), Viking Global (1 company), Venrock (1 company). By latest disclosed round, the market skews Growth (1), Series D (1), Series B (1), Series A (1).
All research · Investor directory · Company funding database · Fundraising library